Pediatric CNS Tumor Patients Have Significantly Lower Requirement of Tissue Plasminogen Activator for Episodes of Central Venous Catheter Dysfunction Compared with Other Pediatric Oncology Patients: Results of a Population-based Cohort Study

Chelsea Howie, Bruce Crooks, Paul Moorehead, Ketan Kulkarni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e623-e626
JournalJournal of Pediatric Hematology/Oncology
Volume42
Issue number7
DOIs
Publication statusPublished - Oct 1 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Pediatric CNS Tumor Patients Have Significantly Lower Requirement of Tissue Plasminogen Activator for Episodes of Central Venous Catheter Dysfunction Compared with Other Pediatric Oncology Patients: Results of a Population-based Cohort Study'. Together they form a unique fingerprint.

Cite this

Howie, C., Crooks, B., Moorehead, P., & Kulkarni, K. (2020). Pediatric CNS Tumor Patients Have Significantly Lower Requirement of Tissue Plasminogen Activator for Episodes of Central Venous Catheter Dysfunction Compared with Other Pediatric Oncology Patients: Results of a Population-based Cohort Study. Journal of Pediatric Hematology/Oncology, 42(7), e623-e626. https://doi.org/10.1097/MPH.0000000000001670